Islet amyloid polypeptide gene variation (IAPP) and the risk of incident type 2 diabetes mellitus: The women's genome health study

Clinica Chimica Acta

Volumn 412, Issue 9-10, 2011, Pages 785-787

  Zee, Robert Y L ^a   Pulido Perez, Patricia ^a,b,c   Perez Fuentes, Ricardo ^b,c   Ridker, Paul M ^a   Chasman, Daniel I ^a   Romero, Jose R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

Author keywords

Diabetes; Gene; IAPP; Risk factor

Indexed keywords

AMYLIN;

ADULT; ARTICLE; CAUCASIAN; FEMALE; FOLLOW UP; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

BODY MASS INDEX; C-REACTIVE PROTEIN; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME; HEALTH; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ISLET AMYLOID POLYPEPTIDE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS;

EID: 79951723091     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.12.040     Document Type: Article

References (10)

1. Hoppener J.W., Ahren B., Lips C.J. Islet amyloid and type 2 diabetes mellitus. N Engl J Med 2000, 343:411-419.
2. Zheng X., Ren W., Zhang S., et al. Serum levels of proamylin and amylin in normal subjects and patients with impaired glucose regulation and type 2 diabetes mellitus. Acta Diabetol 2010, 47:265-270.
3. Kahn S.E., Verchere C.B., Andrikopoulos S., et al. Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans. Diabetes 1998, 47:640-645.
4. Gulli G., Rossetti L., DeFronzo R.A. Hyperamylinemia is associated with hyperinsulinemia in the glucose-tolerant, insulin-resistant offspring of two Mexican-American non-insulin-dependent diabetic parents. Metabolism 1997, 46:1157-1161.
5. Novials A., Rojas I., Casamitjana R., Usac E.F., Gomis R. A novel mutation in islet amyloid polypeptide (IAPP) gene promoter is associated with Type II diabetes mellitus. Diabetologia 2001, 44:1064-1065.
6. Seino S. S20G mutation of the amylin gene is associated with type II diabetes in Japanese. Study Group of Comprehensive Analysis of Genetic Factors in Diabetes Mellitus. Diabetologia 2001, 44:906-909.
7. Garcia-Gonzalez C.L., Montoya-Fuentes H., Padilla-Rosas M., Sanchez-Corona J. Amylin S20G mutation in Mexican population. Diabetes Res Clin Pract 2007, 76:146-148.
8. Hayakawa T., Nagai Y., Ando H., et al. S20G mutation of the amylin gene in Japanese patients with type 2 diabetes. Diabetes Res Clin Pract 2000, 49:195-197.
9. Ridker P.M., Chasman D.I., Zee R.Y., et al. Rationale, design, and methodology of the Women's Genome Health Study: a genome-wide association study of more than 25,000 initially healthy American women. Clin Chem 2008, 54:249-255.
10. Garin I., Martinez R., de las Heras J., Perez-Nanclares G., Castano L., Perez de Nanclares G. Mutations in MAFA and IAPP are not a common cause of monogenic diabetes. Diabet Med 2009, 26:746-748.